vs

Side-by-side financial comparison of FS Bancorp, Inc. (FSBW) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $40.0M, roughly 1.1× FS Bancorp, Inc.). On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 12.0%). FS Bancorp, Inc. produced more free cash flow last quarter ($51.9M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 6.2%).

FS Bancorp, Inc. is a U.S.-headquartered bank holding company that serves as the parent of 1st Security Bank of Washington. It offers a full range of personal and commercial banking solutions including deposit products, mortgage loans, small business financing and construction loans, primarily catering to customers in the Pacific Northwest, with core segments covering retail banking, commercial banking and residential lending.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

FSBW vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.1× larger
PACB
$44.6M
$40.0M
FSBW
Growing faster (revenue YoY)
PACB
PACB
+1.8% gap
PACB
13.8%
12.0%
FSBW
More free cash flow
FSBW
FSBW
$71.9M more FCF
FSBW
$51.9M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
6.2%
FSBW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FSBW
FSBW
PACB
PACB
Revenue
$40.0M
$44.6M
Net Profit
$-40.4M
Gross Margin
37.1%
Operating Margin
25.8%
-92.3%
Net Margin
-90.4%
Revenue YoY
12.0%
13.8%
Net Profit YoY
-1802.7%
EPS (diluted)
$1.11
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FSBW
FSBW
PACB
PACB
Q4 25
$40.0M
$44.6M
Q3 25
$39.3M
$38.4M
Q2 25
$37.3M
$39.8M
Q1 25
$36.1M
$37.2M
Q4 24
$35.7M
$39.2M
Q3 24
$37.2M
$40.0M
Q2 24
$36.3M
$36.0M
Q1 24
$35.5M
$38.8M
Net Profit
FSBW
FSBW
PACB
PACB
Q4 25
$-40.4M
Q3 25
$9.2M
$-38.0M
Q2 25
$7.7M
$-41.9M
Q1 25
$8.0M
$-426.1M
Q4 24
$2.4M
Q3 24
$10.3M
$-60.7M
Q2 24
$9.0M
$-173.3M
Q1 24
$8.4M
$-78.2M
Gross Margin
FSBW
FSBW
PACB
PACB
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
FSBW
FSBW
PACB
PACB
Q4 25
25.8%
-92.3%
Q3 25
29.5%
-101.1%
Q2 25
26.2%
-112.8%
Q1 25
26.2%
-1154.5%
Q4 24
27.6%
-390.1%
Q3 24
26.5%
-160.3%
Q2 24
31.3%
-488.3%
Q1 24
29.7%
-209.6%
Net Margin
FSBW
FSBW
PACB
PACB
Q4 25
-90.4%
Q3 25
23.4%
-98.9%
Q2 25
20.7%
-105.4%
Q1 25
22.2%
-1146.8%
Q4 24
6.0%
Q3 24
27.6%
-151.9%
Q2 24
24.7%
-481.3%
Q1 24
23.7%
-201.4%
EPS (diluted)
FSBW
FSBW
PACB
PACB
Q4 25
$1.11
$-0.11
Q3 25
$1.18
$-0.13
Q2 25
$0.99
$-0.14
Q1 25
$1.01
$-1.44
Q4 24
$0.88
$-0.44
Q3 24
$1.29
$-0.22
Q2 24
$1.13
$-0.64
Q1 24
$1.06
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FSBW
FSBW
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$28.2M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$307.7M
$5.3M
Total Assets
$3.2B
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FSBW
FSBW
PACB
PACB
Q4 25
$28.2M
$279.5M
Q3 25
$61.3M
$298.7M
Q2 25
$33.2M
$314.7M
Q1 25
$62.7M
$343.1M
Q4 24
$31.6M
$389.9M
Q3 24
$40.3M
$471.1M
Q2 24
$33.0M
$509.8M
Q1 24
$45.4M
$561.9M
Stockholders' Equity
FSBW
FSBW
PACB
PACB
Q4 25
$307.7M
$5.3M
Q3 25
$300.5M
$36.1M
Q2 25
$297.2M
$61.5M
Q1 25
$298.8M
$91.6M
Q4 24
$295.8M
$506.6M
Q3 24
$288.9M
$453.1M
Q2 24
$284.0M
$492.7M
Q1 24
$277.9M
$649.0M
Total Assets
FSBW
FSBW
PACB
PACB
Q4 25
$3.2B
$784.1M
Q3 25
$3.2B
$803.2M
Q2 25
$3.2B
$825.5M
Q1 25
$3.1B
$860.8M
Q4 24
$3.0B
$1.3B
Q3 24
$3.0B
$1.5B
Q2 24
$2.9B
$1.5B
Q1 24
$3.0B
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FSBW
FSBW
PACB
PACB
Operating Cash FlowLast quarter
$72.3M
$-19.1M
Free Cash FlowOCF − Capex
$51.9M
$-19.9M
FCF MarginFCF / Revenue
129.8%
-44.6%
Capex IntensityCapex / Revenue
50.9%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$107.2M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FSBW
FSBW
PACB
PACB
Q4 25
$72.3M
$-19.1M
Q3 25
$44.6M
$-18.7M
Q2 25
$7.1M
$-29.4M
Q1 25
$8.2M
$-44.1M
Q4 24
$50.8M
$-30.6M
Q3 24
$-891.0K
$-45.5M
Q2 24
$9.9M
$-54.3M
Q1 24
$275.0K
$-75.7M
Free Cash Flow
FSBW
FSBW
PACB
PACB
Q4 25
$51.9M
$-19.9M
Q3 25
$41.6M
$-18.8M
Q2 25
$5.9M
$-29.9M
Q1 25
$7.8M
$-45.4M
Q4 24
$49.2M
$-32.3M
Q3 24
$-1.5M
$-46.3M
Q2 24
$9.6M
$-55.7M
Q1 24
$-82.0K
$-79.6M
FCF Margin
FSBW
FSBW
PACB
PACB
Q4 25
129.8%
-44.6%
Q3 25
105.9%
-48.9%
Q2 25
15.7%
-75.3%
Q1 25
21.7%
-122.3%
Q4 24
137.7%
-82.3%
Q3 24
-4.1%
-115.7%
Q2 24
26.6%
-154.8%
Q1 24
-0.2%
-205.0%
Capex Intensity
FSBW
FSBW
PACB
PACB
Q4 25
50.9%
1.9%
Q3 25
7.7%
0.2%
Q2 25
3.5%
1.4%
Q1 25
1.0%
3.7%
Q4 24
4.6%
4.1%
Q3 24
1.7%
2.0%
Q2 24
0.8%
4.1%
Q1 24
1.0%
10.0%
Cash Conversion
FSBW
FSBW
PACB
PACB
Q4 25
Q3 25
4.86×
Q2 25
0.92×
Q1 25
1.02×
Q4 24
-12.93×
Q3 24
-0.09×
Q2 24
1.11×
Q1 24
0.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FSBW
FSBW

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons